United Kingdom

Joint working executive summaries

We are involved in a number of joint working projects with various NHS organisations across the country. Find out more about these projects by reading the executive summaries below.

Ashford Clinical Commissioning Group
open
close

Executive Summary of Joint Working between Ashford Clincal Commissioning Group and Teva UK Limited.

The project is being undertaken to ultimately deliver a collaborative pharmacy and surgery inhaler project, which includes inhaler technique training, medicine use review (MUR) training and other support services.

Title of project: Ashford collaborative pharmacy and surgery inhaler project

Project period: the project will run for seven months but can be extended by agreement of all parties.

Project is designed to:

  • Improve the education and experience of asthma patients
  • Train surgery healthcare professionals and community pharmacists on inhaler technique to a consistently high standard
  • Improve the volume, quality and delivery of asthma medicine use reviews (MURs) and asthma reviews by pharmacists and surgeries involved, respectively
  • Improve liaison between practices and the pharmaceutical industry

For further information please contact:

Bristol Clinical Commissioning Group
open
close

Executive Summary of the Joint Working Agreement between Teva UK Limited and Bristol Clinical Commissioning Group: The Bristol Somali Asthma Outreach Project

The project is being undertaken to improve asthma education and to achieve better asthma control for people in the Somali community living in Bristol. The project is taking a novel approach offering tailored support directly to the target community.

Project Period: Both parties have committed resources to the project and the project will run for six months but can be extended by agreement of all parties.

The project is designed to:

  • Increase the level of education around asthma within the community.
  • Increase engagement with primary care health services through education days delivered by Somali speaking healthcare professionals and by running asthma clinics with professional translators in attendance.
  • Reduce emergency asthma admissions from within the Somali community in Bristol.

For further information please contact:

Gloucestershire Clinical Commissioning Group
open
close

Executive Summary of Joint Working between Gloucestershire Clinical Commissioning Group and Teva UK Limited

The project aims to improve the management of asthma patients by running Advanced Inhaler Training (AIT) modules for healthcare professionals through accredited AIT trainers

Project period: Both parties have committed resources to this project and the project will run for a period of 12 months

Project is designed to:

  • Increase patient knowledge and confidence in managing their asthma
  • Implement an educational programme for healthcare professionals to improve their knowledge and practical skills on inhaler technique
  • Reduce and prevent emergency hospital admissions attributed to asthma

For further information please contact:

Newark and Sherwood Clinical Commissioning Group
open
close

Executive Summary of the Joint Working Agreement between Teva UK Limited and Newark and Sherwood Clinical Commissioning Group (NSCCG) to support Education and Training for Spirometry as part of the PANNASH COPD Project

The project is called PANNASH (Pulmonary Advancement Network for Newark and Sherwood), which aims to enhance care for patients with chronic obstructive pulmonary disease (COPD) in Newark and Sherwood.

Teva UK Limited will be responsible for providing spirometry training and education for healthcare professionals within member practices of Newark and Sherwood CCG.

The training will be implemented by a nurse manager and a nurse trainer from The IMPACT service, (Improving the Management of patients asthma and COPD treatment), and is sponsored by Teva UK Limited and delivered by National Services for Health Improvement, (NSHI).

Expected benefits for patients:

  • Patients will benefit from the training as their COPD will be correctly diagnosed, as their healthcare professionals will have greater understanding of spirometry.

Expected benefits for the NHS include:

  • The NHS will benefit from this training as more patients within the Clinical Commissioning Group will be accurately diagnosed and thus are more likely to receive the most appropriate management.

Benefits for Teva UK Limited include:

  • Experience and relationships gained from working with the Newark and Sherwood Clinical Commissioning Group, (and other appropriate stakeholders), in order to help shape members of the steering group and deliver the project via Teva UK Limited.

In addition Teva UK Limited can be seen as a credible supporter of the Clinical Commissioning Group strategy and can demonstrate value to Newark and Sherwood CCG.

For further information please contact:

NHS Bristol
open
close

Executive Summary of Joint Working between NHS Bristol and Teva UK Limited

The project aims to improve asthma management to reduce hospital admissions in NHS Bristol.

Project period: Both parties have committed resources to this project and the project will run for a period of 3 months but can be extended by agreement of all parties.

The project is designed to:

  • Optimise respiratory health and quality of life for asthma patients
  • Increase patient knowledge and confidence in managing their asthma
  • Reduce (prevent) emergency hospital admissions attributed to asthma
  • Improve practice staff knowledge around productive asthma management
  • Develop a high quality patient centred approach to asthma care

For further information please contact:

NHS Sheffield Teaching Hospitals Foundation Trust
open
close

Executive Summary of the Joint Working Agreement between Teva UK Limited and NHS Sheffield Teaching Hospitals Foundation Trust

The project is part of the NHS Test Bed Programme, where Teva UK Limited is an approved innovator partner to the NHS Sheffield Test Bed, a project aiming to create the ‘Perfect Patient PAthway' (PEPPA).

The NHS Sheffield Test Bed is an opportunity to evaluate digital healthcare solutions in a real world environment for people with one or more long term conditions, to support whole patient care and support self-management.

The Test Bed initiative recognises that technology is challenging accepted ways of working in healthcare, with devices and apps opening up the potential to place more control in the hands of patients and make health outcomes more transparent for clinicians. In the face of ageing populations and rising healthcare costs, digital technology could enhance the patient and care provider experience while reducing the financial burden of care. The partnership between Teva and the NHS in the Sheffield City region provides a powerful example of the kind of collaboration between industry and healthcare providers which will be increasingly vital within this emerging digital health landscape. 

In Sheffield, there are approximately 40,000 people – between seven and eight percent of the population – with three or more long-term conditions. The Test Bed will use digital technology, combined with behavioural science and remote patient support, to help patients with multiple long-term conditions manage their health successfully. Teva’s contribution to the Sheffield Test Bed will focus on initially on asthma, employing digital innovation to help asthma patients manage the chronic condition more effectively. 

Project Period: Both parties have committed resources to the project and the project will run for twelve months.

The aims & objectives of the collaboration are to;

  • Undertake a service evaluation of the CareTRx™ Programme to assess the engagement and acceptability of all elements of the CareTRx™ Programme by both healthcare professionals and patients;
  • to support the development of the Sheffield Test Bed Programme by determining the most effective patient pathway for patients with multiple long term conditions (in this case asthma), through the use and implementation of digital and health innovations;
  • to measure the extent to which technology can support people who suffer with long term health conditions to live a healthy and independent life;
  • to evaluate the replicability of the project to support future scale up and spread outside of the scope of the project;
  • to evaluate the impact of combinatorial technology associated with the programme on the identified population group for testing;
  • to improve the quality of life and wellbeing of people suffering with long term health conditions.

For further information please contact:

South Devon & Torbay Clinical Commissioning Group
open
close

Executive Summary of Joint Working between South Devon & Torbay Clinical Commissioning Group and Teva UK Limited

The project is being undertaken to ultimately refresh and enhance healthcare professionals' skills in, and knowledge of, inhaler technique in order to ensure optimal patient outcomes from their prescribed respiratory therapy.

Title of project: Refreshing and enhancing healthcare professional skills in, and knowledge of, inhaler technique in order to ensure optimal patient outcomes from their prescribed respiratory therapy.

Project period: Both parties have committed resources to this project and the project will run for seventeen months but can be extended by agreement of all parties.

The project is designed to:

  • Improve education, adherence and promote healthier outcomes for patients with Asthma and chronic obstructive pulmonary disease (COPD)
  • Help patients use their inhalers more effectively to control their symptoms
  • Improve inhaler technique training among healthcare professionals to a consistently high standard via the accredited course provided by Wales Centre for Pharmacy Professional Education. The course name is Advancing Inhaler Technique
  • Potentially reduce non elective asthma and COPD related hospital admissions

For further information please contact:

Stockport Clinical Commissioning Group
open
close

Executive Summary of the Joint Working Agreement between: Stockport Clinical Commissioning Group and Teva UK Limited

Title of project: STOP IT - Stockport Optimising Inhaler Technique

Project period: Both parties have committed resources to this project and the project will run for a period of 12 months

The project aims to improve the management of asthma and chronic obstructive pulmonary disease (COPD) through supporting a group of healthcare professionals from Stockport CCG to become accredited AIT (Advanced Inhaler Technique) trainers.

Project is designed to: 

  • Increase patients' knowledge and confidence in managing their asthma
  • Improve healthcare professionals' knowledge and practical skills on inhaler technique
  • Reduce and prevent emergency hospital admissions attributed to asthma

For further information please contact:

 

Teva Ref: WN703